| Sr. No. |
Particulars |
Quarter ended 30.06.2008 (Unaudited) |
Quarter ended 30.06.2007 (Unaudited) |
Year ended 31.03.2008 (Audited) |
| 1 |
Net Sales / Income from Operations |
3842.16 |
2886.39 |
12594.22 |
| 2 |
Other income |
2.05 |
1.82 |
40.96 |
| 3 |
Total (1+2) |
3844.21 |
2888.21 |
12635.18 |
| 4 |
Expenditure |
|
|
|
| |
a) (Increase) / Decrease in Stock-in-Trade & Work in Progress |
(167.38) |
35.63 |
205.12 |
| |
b) Consumption of Raw Materials |
2788.67 |
1871.13 |
8984.59 |
| |
c) Employee Cost |
422.06 |
385.76 |
1608.77 |
| |
d) Depreciation and Amortisation |
1175.87 |
1229.48 |
4709.40 |
| |
e) Other Expenditure |
631.78 |
492.76 |
2369.96 |
| |
Total |
4851.00 |
4014.76 |
17877.84 |
| 5 |
Interest |
47.45 |
242.50 |
926.73 |
| 6 |
Exceptional Items |
- |
- |
- |
| 7 |
Profit / (Loss) from Ordinary Activities before Tax (3) - (4+5+6) |
(1054.24) |
(1369.05) |
(6169.39) |
| 8 |
Tax Expense |
|
|
|
| |
- Fringe Benefit Tax |
3.30 |
3.25 |
21.06 |
| |
- Deffered Tax |
- |
- |
- |
| 9 |
Profit / (Loss) from Ordinary Activities after Tax (7-8) |
(1057.54) |
(1372.30) |
(6190.45) |
| 10 |
Extraordinary Items-Income/(Expense) |
- |
- |
1313.88 |
| 11 |
Net Profit /(Loss) (9-10) |
(1057.54) |
(1372.30) |
(4876.57) |
| 12 |
Paid-up Equity Share Capital of Face Value of Rs.2/- each |
7146.06 |
4371.15 |
7146.06 |
| 13 |
Reserves excluding Revaluation reserves |
|
|
60240.96 |
| 14 |
a) Earning Per Share before Extraordinary Items (in Rs.) - |
|
|
|
| |
Basic & Diluted |
(0.30) |
(0.64) |
(2.47) |
| |
b) Earning Per Share after Extraordinary Items (in Rs.) - |
|
|
|
| |
Basic & Diluted |
(0.30) |
(0.64) |
(1.92) |
| 15 |
Public Shareholding |
|
|
|
| |
Number of Shares |
201964202 |
148225952 |
201964202 |
| |
Percentage of shareholding |
56.52% |
67.82% |
56.52% |
| |
|
|
|
|
Notes:
- The above results were reviewed by the audit committee and have been approved by the Board of Directors in its meeting held on 24th July, 2008. A limited review of the same has been carried out by the statutory auditors.
- The Company is exclusively engaged in the Pharmaceutical Business segment.
- The Company has filed an amended application to its Petition u/s 391 of the Companies Act 1956, before the High Court of Himachal Pradesh at Shimla to settle its Fixed Deposit holders. Pending its adjudication, interest of Rs.307.76 Lacs for the quarter on Fixed Deposits has not been provided in the books of accounts, which has also been commented upon by Statutory Auditors.
- Consolidated Income from Operations, Profit(Loss) after tax and EPS for the quarter ended June 30th, 2008 stands at Rs. 4518.02 Lacs, Rs.(-) 1022.43 Lacs & Rs.(-) 0.29 respectively.
- During the Quarter, 5 shareholders' complaints were received which have been attended/redressed.
|
| For and on behalf of the Board |
Place: New Delhi
Date: 24.07.2008 |
(Sushil Suri)
Chairman & Managing Director |
